These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11982719)

  • 1. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants.
    Okuda K
    J Gastroenterol Hepatol; 2002 Apr; 17(4):401-5. PubMed ID: 11982719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma: clinicopathological aspects.
    Okuda K
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S314-8. PubMed ID: 9407352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.
    Yamashita S; Vauthey JN; Kaseb AO; Aloia TA; Conrad C; Hassan MM; Passot G; Raghav KP; Shama MA; Chun YS
    J Gastrointest Surg; 2016 Oct; 20(10):1725-31. PubMed ID: 27456016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
    Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective.
    Takamura H; Gabata R; Obatake Y; Nakanuma S; Hayashi H; Kozaka K; Sasaki M; Okazaki M; Yamaguchi T; Shimbashi H; Terai S; Okamoto K; Makino I; Kinoshita J; Nakamura K; Miyashita T; Tajima H; Ninomiya I; Fushida S; Kitao A; Kitahara M; Arai K; Yamashita T; Yamashita T; Ikeda H; Satoh Y; Harada K; Kaneko S; Gabata T; Kosaka T; Ohta T
    Technol Cancer Res Treat; 2020; 19():1533033820948141. PubMed ID: 33073719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
    Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
    Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
    Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
    Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.
    Koh KC; Lee H; Choi MS; Lee JH; Paik SW; Yoo BC; Rhee JC; Cho JW; Park CK; Kim HJ
    Am J Surg; 2005 Jan; 189(1):120-5. PubMed ID: 15701504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
    Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K
    World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study.
    Ng IO; Shek TW; Nicholls J; Ma LT
    J Gastroenterol Hepatol; 1998 Jan; 13(1):34-40. PubMed ID: 9737569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.